Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
News provided by Eli Lilly and Company May 21, 2026, 06:45 ET In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss, a level long associated with bariatric surgery Individuals with a baseline BMI 35 who participated in a study extension continued to lose weight, and achieved up to an average of 85.0 lbs (30.3%) weight loss at 104 weeks At the 4 mg dose, reached with only a single escalation step, participants lost an average of 47.2 lbs (19.0%) at 80 weeks with a lower observed discontinuation rate due to adverse events vs
Most people use the Sermorelin dosage for muscle growth for three to six months at a time
Third, all-inclusive pricing isn't just a convenience feature - it affects total cost
This raises issues of access those who can afford it may benefit, while others cannot, potentially widening health disparities
Lilly will also continue to offer insulin at no more than $35 per month out-of-pocket, whether a person has commercial insurance or no insurance
US$ 26.09
US$ 20.83
US$ 26.70
US$ 24.01
US$ 20.93
US$ 29.42
US$ 22.34
US$ 21.57
US$ 21.82
